Beam Therapeutics annual asset turnover
2020
2021
2022
2023
2024
2025
Beam Therapeutics Asset Turnover Growth & History (BEAM)
Beam Therapeutics's asset turnover was 0.11 for fiscal 2025.
View full Beam Therapeutics company overviewBeam Therapeutics annual asset turnover history
| Fiscal year | Period ended | Asset turnover | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.11 | 0.06 | +118.18% |
| 2024 | 2024-12-31 | 0.05 | −0.22 | −81.62% |
| 2023 | 2023-12-31 | 0.27 | 0.23 | +523.27% |
| 2022 | 2022-12-31 | 0.04 | −0.01 | −19.63% |
| 2021 | 2021-12-31 | 0.05 | 0.05 | +68062.45% |
| 2020 | 2020-12-31 | 0.00 | — | — |
Beam Therapeutics quarterly asset turnover
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Asset turnover | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.11 | 0.07 | +147.23% |
| Q1 2026 | 2026-03-31 | 0.11 | 0.07 | +147.38% |
| Q4 2025 | 2025-12-31 | 0.11 | 0.06 | +118.18% |
| Q3 2025 | 2025-09-30 | 0.04 | −0.24 | −84.20% |
| Q2 2025 | 2025-06-30 | 0.05 | −0.22 | −83.15% |
| Q1 2025 | 2025-03-31 | 0.04 | −0.22 | −83.22% |
| Q4 2024 | 2024-12-31 | 0.05 | −0.22 | −81.62% |
| Q3 2024 | 2024-09-30 | 0.28 | 0.22 | +359.88% |
| Q2 2024 | 2024-06-30 | 0.27 | 0.21 | +366.25% |
| Q1 2024 | 2024-03-31 | 0.27 | 0.21 | +386.94% |
| Q4 2023 | 2023-12-31 | 0.27 | 0.23 | +523.27% |
| Q3 2023 | 2023-09-30 | 0.06 | −0.01 | −15.81% |
| Q2 2023 | 2023-06-30 | 0.06 | −0.01 | −13.11% |
| Q1 2023 | 2023-03-31 | 0.06 | −0.00 | −1.94% |
| Q4 2022 | 2022-12-31 | 0.04 | −0.01 | −19.63% |
| Q3 2022 | 2022-09-30 | 0.07 | 0.07 | +6638.91% |
| Q2 2022 | 2022-06-30 | 0.07 | 0.07 | +165316.99% |
| Q1 2022 | 2022-03-31 | 0.06 | 0.06 | +118742.59% |
| Q4 2021 | 2021-12-31 | 0.05 | 0.05 | +68062.45% |
| Q3 2021 | 2021-09-30 | 0.00 | — | — |
| Q2 2021 | 2021-06-30 | 0.00 | — | — |
| Q1 2021 | 2021-03-31 | 0.00 | — | — |
| Q4 2020 | 2020-12-31 | 0.00 | — | — |
Beam Therapeutics asset turnover trends
Over the last five fiscal years, Beam Therapeutics's asset turnover increased from 0.00 to 0.11, a change of 0.11. The latest reported quarter, Q2 2026, shows 0.11.
About the metric
What asset turnover means
Asset turnover measures how much revenue a company generates for each unit of assets employed in the business. A higher ratio generally indicates more efficient asset use, although useful comparisons depend heavily on the industry.
Calculation and source
How asset turnover is calculated
TickerStat calculates annual asset turnover as reported revenue divided by average total assets. Quarterly values use trailing-12-month revenue and average assets over the corresponding one-year period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Beam Therapeutics source filings ↗Community posts
Beam reports durable protein correction with experimental AATD therapy
Beam Therapeutics ($BEAM) presented updated Phase 1/2 results for BEAM-302, its experimental gene-editing treatment for alpha-1 antitrypsin deficiency. The presentation covered 29 patients given a single dose, with follow-up extending to 18 ...